2 ms·
They are milking the market up until the patent expires in Canada next year, at which point it’ll be imported into the US at scale. Novo’s already been beaten b
by toomuchtodo 1y ago
They are milking the market up until the patent expires in Canada next year, at which point it’ll be imported into the US at scale. Novo’s already been beaten by Lilly with tirzepatide and orforglipron.
(I pay $350/month cash rate for my partner’s monthly tirzepatide)
https://investor.lilly.com/news-releases/news-release-details/lillys-oral-glp-1-orforglipron-delivers-weight-loss-average-273 https://investor.lilly.com/news-releases/news-release-detail...
How Ozempic's maker lost its shine after creating a wonder drug - https://news.ycombinator.com/item?id=44942077 https://news.ycombinator.com/item?id=44942077 - August 2025
- wpm 1y agoIs that $350/mo for the starter dose or higher?
- dkiebd 1y agoWait, you need a higher dose as time goes on?
- toomuchtodo 1y ago2.5mg starting dose, which is also their maintenance dose.